Jennifer Napora
Nurse Practitioner · Minot, NDNPI 1417594425
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 49.7% of the total. Among nurse practitioner clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$998
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$363
- Alkermes, Inc.$103
- Takeda Pharmaceuticals U.S.A., Inc.$96
- Bayer$82
- AstraZeneca$65
- plus $301 from 10 others
What the payments were for
- Food & beverage$2,007100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 80 | $998 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $363 |
| Alkermes, Inc. | 6 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $96 |
| Bayer | 5 | $82 |
| AstraZeneca | 3 | $65 |
| Lilly USA, LLC | 3 | $65 |
| Pfizer | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$2,007 in reported general payments places this provider in the 90th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 20 | $39,573 |
| OzempicSemaglutide | 25 | $27,139 |
| LatudaLurasidone Hcl | 16 | $22,825 |
| EliquisApixaban | 24 | $19,793 |
| TrintellixVortioxetine Hydrobromide | 29 | $14,530 |
| MounjaroTirzepatide | 12 | $12,308 |
| JardianceEmpagliflozin | 20 | $11,335 |
| LinzessLinaclotide | 14 | $8,781 |
| Icosapent Ethyl | 26 | $4,869 |
| Dexlansoprazole DrDexlansoprazole | 12 | $3,861 |
| Ondansetron OdtOndansetron | 70 | $1,976 |
| Rosuvastatin Calcium | 89 | $1,668 |
| Tizanidine Hcl | 47 | $1,602 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,377 |
| Levothyroxine Sodium | 139 | $1,224 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Linzess | $998 | $48,35434 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $12 | $22,82516 claims |
| PfizerEliquis | $49 | $19,79324 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $96 | $14,53029 claims |
| Lilly USA, LLCMounjaro | $65 | $12,30812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 455 nurse practitioner providers in North Dakota.
Other nurse practitioner in Minot
- Jenna KelschMinot$9K
- Jaclin SeebergMinot$4K
- Wendy HaalandMinot$3K
- Leah BrewsterMinot$3K
- Janet MaxsonMinot$1K
- Emily GreensteinFargo$271K
- Sarah MatchaFargo$17K
- Jana SuderFargo$16K
- Lisa ClairmontBismarck$15K
- McKinzie NussBismarck$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.